🦊/Investors

Borealis Ventures2013 Investments

2 investments dated 2013 · listed companies and verified rows first · show all

Avedroavedro.comin𝕏Mar 2013 · $43Macquired by Glaukos

BiotechHealthtechMedical DevicesWaltham, US

David F. Muller(Executive Officer, Director)inBrian J. Roberts(Executive Officer)inRhonda J. Bracey(Executive Officer)in

BoardJason Hong(Director)Jeff Dykan(Director)inAnthony Natale(Director)in

Co-investorsAPERTURE Venture PartnersLAVLilly Asia VenturesSCP Vitalife PartnersThird Point VenturesHealthQuest Capital+1 more

Avitideavitide.cominSeries A · Mar 2013 · $1Macquired by Repligen

Repligen provides bioprocessing technologies—including process intensification, tangential flow filtration, chromatography, process analytics, and single-use fluid management—for upstream and downstream biopharmaceutical workflows.

BiotechHardwareMedical DevicesLebanon, US

Tillman Gerngross(Director)Errik Anderson(Director)inWarren Kett(Executive Officer)Jon Sheller(Executive Officer)Kevin Issett(Executive Officer, Director)Kevin Isett(Executive Officer, Director)

Co-investorsOrbiMedSV Health InvestorsMithril Capital ManagementPolaris PartnersSands Capital VenturesSV Life Sciences

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.